355 related articles for article (PubMed ID: 11208360)
1. Antitumor effect of electrochemical therapy on transplantable mouse cancers.
Wójcicki M; Droździk M; Olewniczak S; Opolski A; Wietrzyk J; Radzikowski C; Kaczmarek B; Wrzesiński M; Romanowski M; Kamiński M; Zieliński S
Med Sci Monit; 2000; 6(3):498-502. PubMed ID: 11208360
[TBL] [Abstract][Full Text] [Related]
2. Electrochemical treatment of mouse and rat fibrosarcomas with direct current.
Chou CK; McDougall JA; Ahn C; Vora N
Bioelectromagnetics; 1997; 18(1):14-24. PubMed ID: 9125227
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumors.
Ciria HC; Quevedo MS; Cabrales LB; Bruzón RP; Salas MF; Pena OG; González TR; López DS; Flores JM
BMC Cancer; 2004 Nov; 4():87. PubMed ID: 15566572
[TBL] [Abstract][Full Text] [Related]
4. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
5. Treatment of murine tumors using dual-frequency ultrasound in an experimental in vivo model.
Barati AH; Mokhtari-Dizaji M; Mozdarani H; Bathaie SZ; Hassan ZM
Ultrasound Med Biol; 2009 May; 35(5):756-63. PubMed ID: 19195770
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
7. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
8. Clinical and experimental studies of anti-tumoural effects of electrochemical therapy (ECT) alone or in combination with chemotherapy.
Matsushima Y; Takahashi E; Hagiwara K; Konaka C; Miura H; Kato H; Koshiishi Y
Eur J Surg Suppl; 1994; (574):59-67. PubMed ID: 7531023
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of platinum(II) complexes with histamine and radioiodinated histamine in a transplantable murine adenocarcinoma model.
Garnuszek P; Karczmarczyk U; Maurin M
Nucl Med Biol; 2008 Jul; 35(5):605-13. PubMed ID: 18589305
[TBL] [Abstract][Full Text] [Related]
10. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.
Kusmartsev S; Cheng F; Yu B; Nefedova Y; Sotomayor E; Lush R; Gabrilovich D
Cancer Res; 2003 Aug; 63(15):4441-9. PubMed ID: 12907617
[TBL] [Abstract][Full Text] [Related]
11. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
12. Genistein alone or combined with cyclophosphamide may stimulate 16/C transplantable mouse mammary cancer growth.
Wietrzyk J; Mazurkiewicz M; Madej J; Dzimira S; Grynkiewicz G; Radzikowski C; Opolski A
Med Sci Monit; 2004 Nov; 10(11):BR414-9. PubMed ID: 15507846
[TBL] [Abstract][Full Text] [Related]
13. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
14. Factors in transfusion-related enhanced tumor growth.
Ames SA; Shelby J; Roberts LK; Nelson EW
Transplant Proc; 1988 Dec; 20(6):1121-4. PubMed ID: 3201556
[No Abstract] [Full Text] [Related]
15. [Increased anti-tumor activity of chemotherapeutic agents combined with direct current against murine transplanted tumors].
Ito H; Nakayama T; Shigematsu N; Nishiguchi I; Hashimoto S
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1854-9. PubMed ID: 3496048
[TBL] [Abstract][Full Text] [Related]
16. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.
Lorence RM; Katubig BB; Reichard KW; Reyes HM; Phuangsab A; Sassetti MD; Walter RJ; Peeples ME
Cancer Res; 1994 Dec; 54(23):6017-21. PubMed ID: 7954437
[TBL] [Abstract][Full Text] [Related]
17. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
Vaage J; Agarwal S
Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
[TBL] [Abstract][Full Text] [Related]
18. Transplantable mouse 16/C mammary adenocarcinoma as a model in experimental cancer therapy. I. Kinetics of growth and spread.
Rak J; Kuśnierczyk H; Strzadała L; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1988; 36(3):325-34. PubMed ID: 3250355
[TBL] [Abstract][Full Text] [Related]
19. Combined electric field and ultrasound therapy as a novel anti-tumour treatment.
Larkin J; Soden D; Collins C; Tangney M; Preston JM; Russell LJ; McHale AP; Dunne C; O'Sullivan GC
Eur J Cancer; 2005 Jun; 41(9):1339-48. PubMed ID: 15913991
[TBL] [Abstract][Full Text] [Related]
20. [Direct-current treatment of chemically induced mammary carcinoma in an animal model: MR volumetric assessment of the effect of the therapy].
Krüger K; Heindel W; Fielder K; Gossmann A; Kugel H; Schäfer H; Raab M; Li B; Lackner K
Rofo; 1998 Jul; 169(1):85-91. PubMed ID: 9711288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
